These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 18768279

  • 1. Effects of water exchange on MRI-based determination of relative blood volume using an inversion-prepared gradient echo sequence and a blood pool contrast medium.
    Carreira GC, Gemeinhardt O, Beyersdorff D, Schnorr J, Taupitz M, Lüdemann L.
    Magn Reson Imaging; 2009 Apr; 27(3):360-9. PubMed ID: 18768279
    [Abstract] [Full Text] [Related]

  • 2. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M, Zelhof B, Liney GP, Gibbs P, Pickles MD, Turnbull LW.
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [Abstract] [Full Text] [Related]

  • 3. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O, Lüdemann L, Prochnow D, Abramjuk C, Taupitz M, Hamm B, Beyersdorff D.
    Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T, Lüdemann L, Rudolph B, Rehbein H, Staack A, Taupitz M, Prochnow D, Beyersdorff D.
    Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer].
    Franiel T, Lüdemann L, Taupitz M, Rost J, Asbach P, Beyersdorff D.
    Rofo; 2009 Jun; 181(6):536-42. PubMed ID: 19353483
    [Abstract] [Full Text] [Related]

  • 6. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
    Kim JK, Hong SS, Choi YJ, Park SH, Ahn H, Kim CS, Cho KS.
    J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
    [Abstract] [Full Text] [Related]

  • 7. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S, Baghi M, Wagenblast J, Bisdas T, Thng CH, Mack MG, Koh TS, Ernemann U.
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [Abstract] [Full Text] [Related]

  • 8. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
    Oto A, Fan X, Mustafi D, Jansen SA, Karczmar GS, Rubin DT, Kayhan A.
    Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
    [Abstract] [Full Text] [Related]

  • 9. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T, Lüdemann L, Taupitz M, Böhmer D, Beyersdorff D.
    Radiother Oncol; 2009 Nov; 93(2):241-5. PubMed ID: 19748143
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison between prospective and retrospective triggering for mouse cardiac MRI.
    Heijman E, de Graaf W, Niessen P, Nauerth A, van Eys G, de Graaf L, Nicolay K, Strijkers GJ.
    NMR Biomed; 2007 Jun; 20(4):439-47. PubMed ID: 17120296
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA, Cutajar M, Gordon I.
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M, Chaudhari AR, Bailey KL, Aref S, Wiener EC.
    Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
    [Abstract] [Full Text] [Related]

  • 18. Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters.
    Franiel T, Lüdemann L, Rudolph B, Rehbein H, Stephan C, Taupitz M, Beyersdorff D.
    Radiology; 2009 Jul; 252(1):101-8. PubMed ID: 19561252
    [Abstract] [Full Text] [Related]

  • 19. Imaging the distribution of magnetic nanoparticles with ultrasound.
    Norton SJ, Vo-Dinh T.
    IEEE Trans Med Imaging; 2007 May; 26(5):660-5. PubMed ID: 17518060
    [Abstract] [Full Text] [Related]

  • 20. Dynamics of MRI-Guided thermal ablation of VX2 tumor in paraspinal muscle of rabbits.
    Chen X, Barkauskas KJ, Weinberg BD, Duerk JL, Abdul-Karim FW, Paul S, Saidel GM.
    IEEE Trans Biomed Eng; 2008 Mar; 55(3):1004-14. PubMed ID: 18334392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.